國立成功大學 |
2023 |
Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth
|
Wang, K.;Liao, P.-Y.;Chang, W.-C.;Yang, C.-R.;Su, Y.-T.;Wu, P.-C.;Wu, Y.-C.;Hung, Y.-C.;Akhtar, N.;Lai, H.-C.;Ma, W.-L. |
國立成功大學 |
2023 |
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
|
Tsai, P.-C.;Kuo, H.-T.;Hung, C.-H.;Tseng, K.-C.;Lai, H.-C.;Peng, C.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Tai, C.-M.;Lin, C.-W.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, C.-F.;Hsieh, M.-H.;Huang, J.-F.;Dai, C.-Y.;Chung, W.-L.;Chen, Chen C.-Y.;Yu, M.-L. |
國立成功大學 |
2023 |
SYNAPSE: An international roadmap to large brain imaging
|
Stampfl, A.P.J.;Liu, Z.;Hu, J.;Sawada, K.;Takano, H.;Kohmura, Y.;Ishikawa, T.;Lim, J.-H.;Je, Je J.-H.;Low, C.-M.;Teo, A.;Tok, E.S.;Tan, Tan T.W.;Ban, K.;Libedinsky, C.;Tan, F.C.K.;Chen, K.-P.;Yang, A.-C.;Chuang, Chuang C.-C.;Chen, N.-Y.;Shih, C.-T.;Lee, T.-K.;Yang, D.-N.;Lai, H.-C.;Shuai, H.-H.;Cheng, Cheng C.-C.;Ching, Y.-T.;Li, C.-W.;Charng, Charng C.-C.;Lo, C.-C.;Chiang, A.-S.;Recur, B.;Petibois, C.;Cheng, Cheng C.-L.;Chen, H.-H.;Yang, S.-M.;Hwu, Y.;Rojviriya, C.;Rugmai, S.;Rujirawat, S.;Margaritondo, G. |
國立成功大學 |
2023 |
High Entropy Nonlinear Dielectrics with Superior Thermally Stable Performance
|
Wang, Y.-J.;Lai, H.-C.;Chen, Y.-A.;Huang, R.;Hsin, T.;Liu, H.-J.;Zhu, R.;Gao, P.;Li, C.;Yu, P.;Chen, Y.-C.;Li, J.;Chen, Y.-C.;Yeh, J.-W.;Chu, Y.-H. |
臺大學術典藏 |
2022-09-09T04:21:36Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
臺大學術典藏 |
2022-09-09T04:21:35Z |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
|
Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
臺大學術典藏 |
2022-09-09T04:21:34Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO |
臺大學術典藏 |
2022-06-27T07:07:52Z |
Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: The incidence, patient characteristics, and clinical significance
|
Shu C.-C.; Lee C.-H.; Wang J.-Y.; Jerng J.-S.; CHONG-JEN YU; Hsueh P.-R.; Lee L.-N.; Yang P.-C.; Su W.-J.; Lai H.-C.; Yu M.-C. |
臺大學術典藏 |
2022-06-27T07:07:46Z |
Culture result of smear-positive sputum samples after 2 months of antituberculous treatment
|
Lim C.-S.; Lee C.-H.; Chien Y.-J.; Wang J.-Y.; Lee L.-N.; CHONG-JEN YU; Yang P.-C.; Lai H.-C.; Su W.-J.; Shu C.-C.; Yu M.C. |
臺大學術典藏 |
2022-06-27T07:07:30Z |
Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
|
Shu C.-C.; Lee L.-N.; Wu M.-F.; Lee C.-H.; Wang J.-T.; Wang J.-Y.; CHONG-JEN YU; Lee L.-N.; Yang P.-C.; Su W.-J.; Lai H.-C.; Wu V.-C.; Yu M.-C. |
臺大學術典藏 |
2022-06-27T07:06:31Z |
Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: Associated genetic mutations and relationship to antimicrobial exposure
|
Wang J.-Y.; Lee L.-N.; Lai H.-C.; Wang S.-K.; Jan I.-S.; CHONG-JEN YU; Hsueh P.-R.; Yang. P.-C. |
臺大學術典藏 |
2022-06-27T07:06:29Z |
Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis
|
Wang J.-Y.; Lee L.-N.; Lai H.-C.; Hsu H.-L.; Jan I.-S.; CHONG-JEN YU; Hsueh P.-R.; Yang P.-C. |
臺大學術典藏 |
2022-06-27T07:01:53Z |
Sero-diagnosis of mycobacterium avium complex lung disease using serum immunoglobulin a antibody against glycopeptidolipid antigen in Taiwan
|
Shu C.-C.; Ato M.; Wang J.-T.; Jou R.; Wang J.-Y.; Kobayashi K.; Lai H.-C.; CHONG-JEN YU; Lee L.-N.; Luh K.-T. |
臺大學術典藏 |
2022-06-27T07:01:42Z |
Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion
|
Shu C.-C.; Wang J.-Y.; Hsu C.-L.; Keng L.-T.; Tsui K.; Lin J.-F.; Lai H.-C.; CHONG-JEN YU; Lee L.-N.; Luh K.-T. |
臺大學術典藏 |
2022-06-27T07:00:12Z |
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Wu C.-T.; Lai H.-C.; Lee L.-N.; Chiang B.-L.; CHONG-JEN YU |
臺大學術典藏 |
2022-06-27T07:00:10Z |
Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells
|
Shu C.-C.; Wu M.-F.; Wang J.-Y.; Lai H.-C.; Lee L.-N.; Chiang B.-L.; CHONG-JEN YU |
臺大學術典藏 |
2022-06-27T07:00:01Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; CHONG-JEN YU |
臺大學術典藏 |
2022-06-27T06:59:51Z |
Mono- and poly-functional T cells in nontuberculous mycobacteria lung disease patients: Implications in analyzing risk of disease progression
|
Shu C.-C.; Wu L.S.-H.; Wu M.-F.; Lai H.-C.; Wang P.-H.; Cheng S.-L.; Wang J.-Y.; CHONG-JEN YU |
臺大學術典藏 |
2022-06-27T06:59:48Z |
NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
|
Wu M.-F.; Shu C.-C.; Wang J.-Y.; Yan B.-S.; Lai H.-C.; Chiang B.-L.; Wu L.S.-H.; CHONG-JEN YU |
臺大學術典藏 |
2022-05-13T08:04:52Z |
Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
|
Shu C.-C.; Lee L.-N.; Wu M.-F.; Lee C.-H.; JANN-TAY WANG; Wang J.-Y.; Yu C.-J.; Lee L.-N.; Yang P.-C.; Su W.-J.; Lai H.-C.; Wu V.-C.; Yu M.-C. |
臺大學術典藏 |
2022-05-13T08:04:43Z |
Sero-diagnosis of mycobacterium avium complex lung disease using serum immunoglobulin a antibody against glycopeptidolipid antigen in Taiwan
|
Shu C.-C.; Ato M.; JANN-TAY WANG; Jou R.; Wang J.-Y.; Kobayashi K.; Lai H.-C.; Yu C.-J.; Lee L.-N.; Luh K.-T. |
臺大學術典藏 |
2022-05-10T08:09:24Z |
Month of birth and the risk of narcolepsy: a systematic review and meta-analysis
|
Hsu C.-W.; Tseng P.-T.; YU-KANG TU; Lin P.-Y.; Wang L.-J.; Hung C.-F.; Yang Y.-H.; Kao H.-Y.; Yeh C.-B.; Lai H.-C.; Chen T.-Y. |
臺大學術典藏 |
2022-05-03T06:19:32Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen L.-S.; Liao C.-S.; SHU-HUI CHANG; Lai H.-C.; Chen T.H.-H. |
臺大學術典藏 |
2022-04-21T06:51:43Z |
Community-Based Multiple Screening Model: Design, Implementation, and Analysis of 42,387 Participants Taiwan Community-Based Integrated Screening Group
|
Chen, Tony Hsiu Hsi; Chiu Y.-H.; Luh D.-L.; Yen M.-F.; Wu H.-M.; Chen L.-S.; Tung T.-H.; Huang C.-C.; Chan C.-C.; Shiu M.-N.; Yeh Y.-P.; Liou H.-H.; Liao C.-S.; Lai H.-C.; Chiang C.-P.; Peng H.-L.; Tseng C.-D.; Yen M.-S.; Hsu W.-C.; Chen C.-H. |
臺大學術典藏 |
2022-04-21T06:51:31Z |
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries
|
Wu G.H.-M.; Wang Y.-W.; Yen A.M.-F.; Wong J.-M.; Lai H.-C.; Warwick J.; Chen, Tony Hsiu Hsi |
臺大學術典藏 |
2022-04-21T06:51:17Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen L.-S.; Liao C.-S.; Chang S.-H.; Lai H.-C.; Chen, Tony Hsiu Hsi |
臺大學術典藏 |
2022-03-24T07:01:35Z |
Quantifying spatial heterogeneity of vulnerability to short-term PM2.5 exposure with data fusion framework
|
Kuo C.-P.; Fu J.S.; Wu P.-C.; Cheng T.-J.; Chiu T.-Y.; Huang C.-S.; CHANG-FU WU; Lai L.-W.; Lai H.-C.; Liang C.-K. |
臺大學術典藏 |
2022-03-24T03:27:41Z |
Community-Based Multiple Screening Model: Design, Implementation, and Analysis of 42,387 Participants Taiwan Community-Based Integrated Screening Group
|
Chen T.H.-H.; Chiu Y.-H.; Luh D.-L.; Yen M.-F.; Wu H.-M.; Chen L.-S.; Tung T.-H.; Huang C.-C.; CHANG-CHUAN CHAN; Shiu M.-N.; Yeh Y.-P.; Liou H.-H.; Liao C.-S.; Lai H.-C.; Chiang C.-P.; Peng H.-L.; Tseng C.-D.; Yen M.-S.; Hsu W.-C.; Chen C.-H. |
臺大學術典藏 |
2022-03-04T05:33:31Z |
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; CHEN-TU WU; Lai H.-C.; Lee L.-N.; Chiang B.-L.; Yu C.-J. |
臺大學術典藏 |
2022-02-18T08:26:03Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. |
臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
臺大學術典藏 |
2022-02-14T06:28:43Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; YU-JEN FANG; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:31:33Z |
Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients
|
Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; Hsu S.-J.; Lai H.-C.; Su C.-W.; CHUN-JEN LIU; Peng C.-Y.; Yu M.-L. |
臺大學術典藏 |
2022-01-24T09:31:23Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; CHUN-JEN LIU; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. |
臺大學術典藏 |
2022-01-24T09:31:11Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:31:10Z |
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
|
Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; CHUN-JEN LIU; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:31:05Z |
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L. |
臺大學術典藏 |
2022-01-24T09:31:04Z |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group |
臺大學術典藏 |
2022-01-24T09:31:03Z |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
臺大學術典藏 |
2022-01-24T09:31:02Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:30:58Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:30:55Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
臺大學術典藏 |
2022-01-24T09:30:54Z |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
|
Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
臺大學術典藏 |
2022-01-24T09:30:53Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU; Yu M.-L. |
臺大學術典藏 |
2022-01-24T09:30:53Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
國立成功大學 |
2022 |
Month of birth and the risk of narcolepsy: A systematic review and meta-analysis
|
Hsu, C.-W.;Tseng, P.-T.;Tu, Y.-K.;Lin, P.-Y.;Wang, L.-J.;Hung, C.-F.;Yang, Yang Y.-H.;Kao, H.-Y.;Yeh, C.-B.;Lai, H.-C.;Chen, T.-Y. |
國立成功大學 |
2022 |
Review of the endocrine organ–like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma
|
Yu, Yu Y.-C.;Ahmed, Ahmed A.;Lai, H.-C.;Cheng, W.-C.;Yang, J.-C.;Chang, W.-C.;Chen, L.-M.;Shan, Y.-S.;Ma, W.-L. |
臺大學術典藏 |
2021-11-30T04:54:25Z |
Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
|
Shu C.-C.; Lee L.-N.; Wu M.-F.; Lee C.-H.; Wang J.-T.; Wang J.-Y.; Yu C.-J.; Lee L.-N.; Yang P.-C.; Su W.-J.; Lai H.-C.; VIN-CENT WU; Yu M.-C. |